Permethrin poisoning. Permethrin is a pyrethroid, a synthetic. Keeping cats safe. Key point

Similar documents
Poisoning in cats: toxic triggers and raising owner awareness

Benzalkonium chloride (BAC, Benzalkonium chloride exposure in cats. Keeping cats safe

Keeping cats safe: introduction to toxicology. This article introduces our series. Key point

Insecticide Toxicities in Cats

Therapeutic Updates in Veterinary Toxicology

SUMMARY OF PRODUCT CHARACTERISTICS

Ylva Sjöström 1) and Anna Lennquist 2)

SUMMARY OF PRODUCT CHARACTERISTICS

DISSOCIATIVE ANESTHESIA

Veterinary Poisons Information Service (VPIS)

SUMMARY OF PRODUCT CHARACTERISTICS. Euthasol vet. 400 mg/ml, solution for injection (AT, BE, DK, EE, EL, FI, IE, IS, LT, LU, LV, NO, PL, RO SE, UK)

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection

Intravenous lipid emulsion and dexmedetomidine for treatment of feline permethrin intoxication: a report from 4 cases

EMEDOG 1mg/ml Solution for injection for dogs. Part I ADMINISTRATIVE DATA AND SUMMARY OF THE DOSSIER

NSAID Toxicity in Dogs & Cats Beware of Ibuprofen!

Indicated for the treatment of pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis in dogs.

SUMMARY OF PRODUCT CHARACTERISTICS

For the treatment of mixed parasitic infections in cats caused by roundworms and tapeworms of the following species:

Please refer to Table 1 Dosage and Treatment Schedule TABLE 1 Species Product Number of Tubes Cats. Rabbits or Advantage 40 for Cats

Veterinary Poisons Information Service (VPIS)

Summary of Product Characteristics

Health Products Regulatory Authority

MURDOCH RESEARCH REPOSITORY.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

Metacam 1.5 mg/ml oral suspension for dogs

Summary of Product Characteristics

Sites of IM injections : 1. Ventrogluteal site: site is in the gluteus medius muscle, which lies over the gluteus minimus. 2. Vastus lateralis site:

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

ADVANTAGE FOR DOGS

Pets: Dog and Cat External Parasites 7-1. Insecticide Active Ingredient [% A.I. in product] Mixing and Application Information Precautions

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

A New Advancement in Anesthesia. Your clear choice for induction.

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

American Association of Feline Practitioners American Animal Hospital Association

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT

Poisoning in Dogs Knowing the Risks and Steps in an Emergency

This drug SHOULD NOT be used in: XXPregnant or nursing animals. XXDogs that are weak, old, or frail.

Pets: Dog and Cat External Parasites 7-1. Insecticide Active Ingredient [% A.I. in product] Mixing and Application information Precautions

IS THE USE OF DCR-1339 HUMANE? Prof. Joan Dawes

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

MATERIAL SAFETY DATA SHEET Maxforce Gold Gel Insecticide

Canadian Label Improvement Program for Pesticides Used on Companion Animals

Lufenuron. Technical Profile

AMITRAZ TOXICITY DIAGNOSTIC CRITERIA. Physical Examination Findings. Chiara Valtolina, DVM, MRCVS* Resident in Emergency and Critical Care

INCIDE 25 FLY KILLER SURFACE AND TOPICAL SPRAY AGRICULTURAL. Main Panel English: InCide 25 Fly Killer ml 3 INSECTICIDE

discover the nextgeneration of flea & tick protection NEW TASTY CHEW ONE CHEW ONCE A MONTH

The induction of emesis in dogs

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Bayer Environmental Science SAFETY DATA SHEET according to Regulation (EC) No. 1907/2006

RESEARCH REPOSITORY.

Period of study: 12 Nov 2002 to 08 Apr 2004 (first subject s first visit to last subject s last visit)

Summary of Product Characteristics

Feline blood transfusions: preliminary considerations

SUMMARY OF PRODUCT CHARACTERISTICS

WEST WHITELAND TOWNSHIP PUBLIC SERVICES COMMISSION

Questions and answers on serious non-fatal adverse events and reporting rules

MARBOCYL FD SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Equest Oral Gel, 18,92 mg/g, Oral Gel for Horses and Ponies

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

The Reconsideration of Approvals and Registrations Relating to FIPRONIL

MATERIAL SAFETY DATA SHEET Maxforce Gold Gel Insecticide

Public bulletin - Veterinary pharmacovigilance 2010

Pollutants of Emerging Concern in Orange County Stormwater. Synthetic Pyrethroid Pesticides Fipronil Pesticide

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: Imidacloprid 40 mg/pipette (0.4 ml of a 10 % solution)

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Susan Becker DNP, RN, CNS, CCRN, CCNS Marymount University, Arlington, VA

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Mosquitoes & Diseases. Maxwell Lea, Jr. DVM State Veterinarian Louisiana Dept. of Agriculture and Forestry Department of Animal Health Services

Dexmedetomidine. Dr.G.K.Kumar,M.D.,D.A., Assistant Professor, Madras medical college,chennai. History

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Comparative Evaluation of the Speed of Flea Kill of Imidacloprid and Selamectin on Dogs*

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT

LUPIN LIMITED SAFETY DATA SHEET. Section 1: Identification MADE IN INDIA

SUMMARY OF PRODUCT CHARACTERISTICS

Health Products Regulatory Authority

Pain Management in Racing Greyhounds

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

ISMP Canada HYDROmorphone Knowledge Assessment Survey

4.5. Special precautions for use Special precautions to be taken by person administering the veterinary medicinal product to animals

Australian and New Zealand College of Veterinary Scientists. Fellowship Examination. Veterinary Anaesthesia and Critical Care Paper 1

WARNING KEEP OUT OF REACH OF CHILDREN DO NOT USE ON CATS. Code: pvasmmd

Dr. Omar S. Tabbouche, M.Sc, D.Sc, Pharm.D Head of Pharmacy Department New Mazloum Hospital Tripoli, Lebanon

SUMMARY OF PRODUCT CHARACTERISTICS

MOXIDECTIN SPOT-ON SOLUTION FOR KITTENS AND SMALL CATS. 280 mg/ml FLURALANER 14 mg/ml MOXIDECTIN Also contains: 339 mg/ml DIMETHYLACETAMIDE (solvent)

Summary of Product Characteristics

T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods

Oral sedation of horses

Fungal Disease. What is a fungus?

A monthly spot-on treatment for puppies and dogs.

Perioperative Care of Swine

Transcription:

Permethrin poisoning Permethrin is one of the most common poisons affecting cats. In most cases they are exposed to concentrated canine spot-on flea treatment products, either through accidental application or secondary contamination from a treated dog. Permethrin poisoning typically causes body tremors and twitching, hyperaesthesia, seizures, pyrexia, ataxia and dilated pupils which can take hours or days to manifest. Treatment usually involves prolonged hospitalisation and is aimed at controlling tremors and seizure activity, dermal decontamination, maintaining body temperature and good nursing care. Recently lipid infusion has been shown to be a very promising treatment in the management of permethrin toxicosis in cats. Permethrin is a pyrethroid, a synthetic pyrethrin. Pyrethrins are naturally occurring insecticides extracted from the flowers of Chrysanthemum cinerariaefolium. Pyrethrins and pyrethroids are insecticides used therapeutically on animals (cats, dogs, rodents, birds, sheep, cattle, poultry, horses, goats and humans), and to prevent/treat domestic and agricultural insect infestations. Preparations are available for home and agricultural use as dusting powders, liquids, bait stations (usually a small plastic receptacle which contains a small quantity of insecticide and an attractant such as peanut butter), and sprays, or to be used directly on animals as Key point Cats are typically exposed to permethrin when dog flea products are applied in error, or they come into contact with a treated dog. Nicola Bates BSc (Brunel) BSc (Open) MSc MA Nicola has worked in human and veterinary toxicology for 25 years and has been with the Veterinary Poisons Information Service (VPIS) since it started. As well as providing emergency advice via telephone she has written extensively on veterinary toxicology. In addition to service provision, she is involved in training of VPIS staff and veterinary professionals. She is currently the congress abstract editor for the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). spot-on treatments, shampoo, flea sprays or flea collars. Exposure in cats Cats are typically poisoned with permethrin when they come into contact with a canine spot-on flea treatment. This usually occurs after the product is applied to the cat in error or after the cat comes into contact with a treated dog. There are a few products licensed for use in cats (mostly flea collars and flea powders). The flea powders contain a low concentration of permethrin (1% or less) and do not seem to cause the signs seen with canine spot-on products which in contrast contain much higher concentrations

of permethrin (eg, some spot-on products contain 744 mg/ml, so is 74.4% permethrin). Toxicity has also been reported with spot-on products that contain 45 65% permethrin. 1 Individual response in cats is variable and toxicity can occur from a drop of a highly concentration canine spot on product. 2 Mechanisms of toxicity Pyrethroids and pyrethrins cause hyperexcitability in cells by slowing the opening and closing of sodium channels in nerve membranes. Signs of poisoning are therefore neuroexcitatory in nature. In most mammals pyrethrins and pyrethroids are rapidly biotransformed and detoxified by ester hydrolysis or oxidation and as a result these compounds are of relatively low toxicity. The feline liver, however, is relatively inefficient at glucuronide conjugation. This leads to slow excretion and accumulation of metabolites and may be the reason for the increased susceptibility of cats to permethrin poisoning. Pyrethroids and pyrethrins are lipophilic and if repeatedly administered can accumulate in fatty tissues. A number of studies, 3 6 have noted that toxicity is more common in young cats (<4 years, particularly <1 year) but the reason for this is unclear. It may be due to small samples size in studies. Clinical signs Clinical signs may occur within a few hours but can take 24 72 h to manifest. 5 Typically there is body tremor and twitching, hyperaesthesia, seizures, pyrexia, ataxia and dilated pupils. Less common effects include ear flicking, head tilt, hallucinations, dyspnoea, cyanosis, temporary blindness and cardiac arrhythmias. Potential complications include pyrexia or hypothermia, aspiration pneumonia, apnoea, respiratory or cardiac arrest. 6 Prolonged controlled seizure may result in cerebral oedema, irreversible brain damage Table 1: Fatality rate in permethrin-poisoned cats in various studies Source Reference Deaths/ total cases Fatality rate Australia 1/20 5% Dymond and Swift 2008 4 Sweden 7/77 9% Holmgren and Hulten 2007 19 VPIS data 30/286 10.5% Sutton et al 2007 8 Australian Pesticides and Veterinary 6/26 23% Linnett 2008 5 Medicines Authority s Adverse Experience Reporting Program A single veterinary hospital, Australia 8/42 19% Boland and Angles 2010 6 UK Veterinary Medicines Directorate 10/27 37% Gray 2000 20 (VMD) US Environmental Protection Agency (EPA) incident data 39/87 45% Meyer 1999 1 Survey of Australian veterinary 166/750 22% Malik et al 2010 9 practitioners Total 267/1315 20% XXX icatcare.org/felinefocus

and breakdown of muscle tissue could cause myoglobinuria-induced nephropathy. 7 In a review of 286 cases the mean overall recovery was 61.5 h (range 3 h to 7 days). 8 In a review of 41 cases the mean hospitalisation time was 3 days (range 0.5 11 days). 6 Prognosis Prognosis depends on the severity of signs. Various studies have determined the fatality rate in cats poisoned with permethrin to vary from 5 45% (Table 1). Treatment may be required for several days and in some cases cats are euthanased because of cost issues. In one study, 5.2% of cats were euthanased due to financial constraints. 9 In addition, these studies do not include cases where lipid infusion was used. It is possible that treatment with lipid infusion may have reduced the fatality rate in permethrin toxicosis in cats. The prognosis is poor in cats with uncontrolled seizure activity. Tip Cats should be washed with lukewarm water and washing up detergent to remove the permethrin from the skin. Diagnosis There are no routine tests to confirm permethrin exposure. Diagnosis is usually based on clinical signs and history of the use of a spot-on flea treatment. Cats treated with a spoton product may have a greasy patch on the back of the neck. Differential diagnosis will include metabolic abnormalities (eg, hypocalcaemia, hypoglycaemia), intracranial disease, trauma and other toxicities (eg, metaldehyde, strychnine, tremorgenic mycotoxins, lead poisoning, bromethalin). Treatment Decontamination Cats with tremors or seizures should be stabilised before decontamination, as handling can exacerbate tremors or seizure activity. Ingestion After ingestion permethrin is rapidly absorbed and so emetics are unlikely to be of use. In addition unless there is significant oral exposure oral decontamination is generally unnecessary. The effectiveness of adsorbents is questionable due to the non-polar nature of these agents (activated charcoal does not bind well to nonpolar molecules) and is best avoided because of the risk of seizures. Dermal Cats should be washed with lukewarm water and detergent (pyrethrins and pyrethroids are not water soluble). The use of hot water should be avoided as this increases dermal perfusion and may result in increased dermal absorption. Cats with long hair may need to have exposed areas clipped. Care should be taken to dry the animal well. A decrease in body temperature may exacerbate effects due to an inverse relationship between sodium influx and temperature. 3 Following decontamination the cat should be collared to prevent grooming and also isolated from other animals to prevent cross contamination. Management of increased muscular activity Diazepam may be of use to control increased muscular activity (twitching, fasciculation or convulsions) but severe neuromuscular activity may be difficult to control with diazepam alone. Methocarbamol, a centrally acting skeletal muscle relaxant, has been effective where

benzodiazepines have failed. 7,10,11 Methocarbamol, however, has limited veterinary availability and experience in the UK. In addition it is only available as tablets however, these can be crushed and given either via a gastric tube in sedated animals or rectally. A combination of diazepam and methocarbamol can be used for refractory convulsions. 10 Barbiturates of full anaesthesia with propofol may be required in severe cases. 7 Lipid infusion Lipid infusion is a relatively new treatment which can be very effective in the management of poisoning with lipophilic compounds such as permethrin. It uses the intravenous administration of lipid emulsion (see Box 1) which is more commonly used as parenteral nutrition cases. The exact mechanism of action of lipid infusion is not fully understood but various hypotheses have been proposed. The lipid component formed in the blood may act as a sink or shuttle leading to redistribution of the toxic compound. Lipid infusion has been used successfully in cases of permethrin poisoning in cats.12 16 A randomised, controlled clinical trial in cats with permethrin toxicity compared cats treated with and without lipid infusion. The study used a specially designed and validated system describing six clinical stages of poisoning. The study found that cats treated with lipid infusion improved earlier than cats that did not receive the infusion. 17 Administration of lipids in animals receiving therapy with lipophilic drugs such as propofol has been raised as a potential concern; however the use of lipid is expected Box 1: Lipid infusion regimen There is no standard regimen for lipid infusion in the management of poisoning. Usually, 1.5 ml/kg of a 20% lipid emulsion is given intravenously as a bolus dose. A bolus dose of up to 4 ml/kg in dogs is also suggested. 21 This is followed by an infusion (0.25 ml/kg/min over 30 60 minutes). This can be repeated once or twice and if no response can be discontinued. If there is a response it is generally repeated when signs recur. Intermittent bolus doses of 1.5 ml/kg every 4 6 h for the initial 24 h has also been used. 21 The most commonly used product is Intralipid 20% but other products are available. to reduce the need for such emergency therapy. The potential effect of lipid infusion on concentrations of other therapeutic agents, including antidotes, should be assessed on an individual case basis. Only a small quantity of lipid crosses the blood brain barrier and for propofol at least the effect of lipid on propofol-induced sedation is expected to be low. 18 Early use of lipid infusion is recommended if the exposure is thought to be significant, the cat has significant neurological signs or is failing to respond to other therapies. Rapid improvement can occur in cats with permethrin poisoning given intravenous lipids. 13,15 Other care Good nursing care is essential as cats may require sedation for a prolonged period. Body temperature should be monitored closely because it can fluctuate due to tremors, bathing and the use of sedatives or muscle relaxants. Intravenous fluids may be helpful to XXX icatcare.org/felinefocus

maintain urine output and prevent myoglobin-induced renal failure. Nutritional support may be necessary in severely affected cats. Airway protection may be required in some cases depending on the degree of sedation necessary to control seizure activity. Cooling measures should be used carefully, as a low body temperature may lead to increased toxicity. Atropine is not an antidote to permethrin toxicity and may exacerbate tachycardia which is often present in cats with permethrin toxicity. Prevention It is important to educate owners on the risks of permethrin to cats and in households with both a dog and cat to provide information on flea treatments that are safe for both species (see Figure 1). Kill the flea. Not the cat. Permethrin spot-on flea products for dogs can kill cats Ask your vet for advice on safe flea treatments for your cat icatcare.org/permethrin Conclusions Permethrin is one of the most common poisons affecting cats. It causes severe neurological signs necessitating prolonged treatment and hospitalisation. Cats can survive if treatment is prompt and aggressive with control of seizures. Lipid infusion is a very promising treatment in the management of permethrin toxicosis in cats. Figure 1: International Cat Care s permethrin campaign poster. (Download at: http://icatcare.org/sites/def ault/files/pdf/ permethrin_poster_vet.pdf) References 1 Meyer EK. Toxicosis in cats erroneously treated with 45% to 65% permethrin products. J Am Vet Med Assoc 1999; 215: 198 203. 2 Anadón A, Martínez-Larrañaga MR, Martínez MA. Use and abuse of pyrethrins and synthetic pyrethroids in veterinary medicine. Vet J 2009; 182: 7 20. 3 Whittem T. Pyrethrin and pyrethroid insecticide intoxication in cats. Compend Contin Educ Vet Practit 1995; 17, 489 492. 4 Dymond NL, Swift IM. Permethrin toxicity in cats: a retrospective study of 20 cases. Aust Vet J 2008; 86: 219 223. 5 Linnett P-J. Permethrin toxicosis in cats. Aust Vet J 2008; 86: 32 35. 6 Boland LA, Angles JM. Feline permethrin toxicity: retrospective study of 42 cases. J Feline Med Surg 2010; 12: 61 71. 7 Richardson JA. Permethrin spot-on toxicosis in cats. J Vet Emerg Crit Care 1999; 10: 103 106. 8 Sutton NM, Bates, N and Campbell A. Clinical effects and outcome of feline permethrin spot-on poisonings reported to the Veterinary Poisons Information Service (VPIS), London. J Feline Med Surg 2007; 9: 335 339. 9 Malik R, Ward MP, Seavers A, Fawcett A, Bell E, Govendir M, et al. Permethrin spot-on intoxication of cats: literature review and survey of veterinary practitioners in Australia. J Feline Med Surg 2010; 12: 5 14. 10 Volmer PA, Khan SA, Knight MW, Hansen SR. Warning against use of some permethrin products in cats. J Am Vet Med Assoc 1998; 213: 800 801. 11 Hansen SR. Pyrethrins and pyrethroids. In: Peterson ME and Talcott PA (eds). Small animal toxicology, 3rd ed. Elsevier Saunders, St Louis, 2013, pp 769 775. 12 Brückner M, Schwedes CS. Successful treatment of permethrin toxicosis in two cats with an intravenous lipid administration. Tierarztl Prax Ausg K Kleintiere Heimtiere 2012; 40: 129 134. 13 Haworth MD and Smart L. Use of intravenous lipid therapy in three cases of feline permethrin toxicosis. J Vet Emerg Crit Care 2012; 22: 697 702. 14 Kuo K and Odunayo A. Adjunctive therapy with intravenous lipid emulsion and methocarbamol for permethrin toxicity in 2 cats. J Vet Emerg Crit Care 2013; 23: 436 441. 15 Muentener CR, Spicher C and Page SW. Treating permethrin poisoning in cats. Vet Rec 2013; 172: 643. 16 DeGroot WD. Intravenous lipid emulsion for treating permethrin toxicosis in a cat. Can Vet J 2014; 55: 1253 1254. (Erratum in: Can Vet J 2014; 55: 106.) 17 Peacock RE, Hosgood G, Swindells KL and Smart L. A randomized, controlled clinical trial of intravenous lipid emulsion as an adjunctive treatment for permethrin toxicosis in cats. J Vet Emerg Crit Care (San Antonio) 2015; 25: 597 605. 18 Gragasin FS, Davidge ST and Tsui BC. The potential use of intralipid to minimize propofol's cardiovascular effects. Can J Anesth 2009; 56: 170-171. 19 Holmgren A and Hulten P. Permethrin poisoning in cats: a case series [abstract]. Clin Toxicol 2007; 45: 358. 20 Gray A. Permethrin toxicity in cats. Vet Rec 2000; 147: 556. 21 Fernandez AL, Lee JA, Rahilly L, Hovda L, Brutlag AG and Engebretsen K. Use of intravenous lipid emulsion as an antidote in veterinary toxicology. J Vet Emerg Crit Care 2011; 21: 309 320.